Signal
Moderna will pay $950 million upfront—and no future royalties—to settle patent litigation over its mRNA-based vaccine Spikevax. The case was brought by Roiva...
Evidence first: scan the strongest sources, then decide whether to go deeper.
Published 2026-03-04 13:19 UTCUpdated 2026-03-04 19:25 UTC
MRNA
rssx
mrnapayments
Source links open
Source links and full evidence are open here. Archive history, compare-over-time, alerts, exports, API, integrations, and workflow are paid.
No card needed for the free brief.
Evidence trail (top sources)
top sources (3 domains)domains are deduped. counts indicate coverage, not truth.3 top sources shown
Overview
Moderna agrees $950m settlement of mRNA jab litigation Phil.Taylor Wed, 04/03/2026 - 13:19.
Score total
1.59
Momentum 24h
4
Posts
4
Origins
3
Source types
2
Duplicate ratio
25%
All evidence
All evidence
Moderna to pay up to $2.25B to end mRNA vaccine patent fight
BioPharma Dive · biopharmadive.com · 2026-03-04 17:06 UTC
Moderna will pay $950 million upfront—and no future royalties—to settle patent litigation over its mRNA-based vaccine Spikevax. The case was brought by Roivant subsidiary Geneva...
Fierce Pharma (All) · fiercepharma.com · 2026-03-04 15:37 UTC
Moderna agrees $950m settlement of mRNA jab litigation
pharmaphorum · pharmaphorum.com · 2026-03-04 13:19 UTC
Show filters & breakdown
Posts loaded: 0Publishers: 3Origin domains: 3Duplicates: -
Showing 3 / 0
Top publishers (this list)
- BioPharma Dive (1)
- Fierce Pharma (All) (1)
- pharmaphorum (1)
Top origin domains (this list)
- biopharmadive.com (1)
- fiercepharma.com (1)
- pharmaphorum.com (1)